-
1
-
-
0345696854
-
Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
-
Guilhot F, Chastang C, Michallet M et al. Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. N Engl J Med 1997; 337: 223-229.
-
(1997)
N. Engl. J. Med.
, vol.337
, pp. 223-229
-
-
Guilhot, F.1
Chastang, C.2
Michallet, M.3
-
2
-
-
0342541022
-
Long term follow-up of the Italian trial of interferon-alpha versus conventional chemotherapy in chronic myeloid leukemia
-
The Italian Cooperative Study Group on Chronic Myeloid Leukemia
-
The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Long term follow-up of the Italian trial of interferon-alpha versus conventional chemotherapy in chronic myeloid leukemia. Blood 1998; 92: 1541-1548.
-
(1998)
Blood
, vol.92
, pp. 1541-1548
-
-
-
3
-
-
0035810147
-
Efficacy and safety of a specific inhibitor of the bcr-abl tyrosine kinase in chronic myeloid leukemia
-
Druker B, Talpaz M, Resta D et al. Efficacy and safety of a specific inhibitor of the bcr-abl tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031-1037.
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 1031-1037
-
-
Druker, B.1
Talpaz, M.2
Resta, D.3
-
4
-
-
0037186915
-
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia
-
Kantarjian H, Sawyers C, Hochhaus A et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 2002; 346: 645-652.
-
(2002)
N. Engl. J. Med.
, vol.346
, pp. 645-652
-
-
Kantarjian, H.1
Sawyers, C.2
Hochhaus, A.3
-
5
-
-
13044294682
-
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology
-
Silver RT, Woolf SH, Hehlmann R et al. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. Blood 1999; 94: 1517-1536.
-
(1999)
Blood
, vol.94
, pp. 1517-1536
-
-
Silver, R.T.1
Woolf, S.H.2
Hehlmann, R.3
-
6
-
-
0025360234
-
Bone marrow transplantation in comparison with conventional therapy in children with adult type chronic myelogenous leukemia
-
Klingebiel T, Creutzig U, Dopfer R et al. Bone marrow transplantation in comparison with conventional therapy in children with adult type chronic myelogenous leukemia. Bone Marrow Transplant 1990; 5: 317-320.
-
(1990)
Bone Marrow Transplant.
, vol.5
, pp. 317-320
-
-
Klingebiel, T.1
Creutzig, U.2
Dopfer, R.3
-
7
-
-
0027156513
-
Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children
-
Gamis AS, Haake R, McGlave P, Ramsey NK. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children. J Clin Oncol 1993; 11: 834-838.
-
(1993)
J. Clin. Oncol.
, vol.11
, pp. 834-838
-
-
Gamis, A.S.1
Haake, R.2
McGlave, P.3
Ramsey, N.K.4
-
8
-
-
0032446345
-
Treatment of Ph1-positive chronic myelogenous leukemia in children: Comparison between allogeneic bone marrow transplantation and conventional chemotherapy
-
Munoz A, Bureo E, Ortega JJ et al. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Haematologica 1998; 83: 981-984.
-
(1998)
Haematologica
, vol.83
, pp. 981-984
-
-
Munoz, A.1
Bureo, E.2
Ortega, J.J.3
-
9
-
-
0021344640
-
Bone marrow transplantation for chronic myelogenous leukemia
-
Speck B, Bortin MM, Champlin R. Bone marrow transplantation for chronic myelogenous leukemia. Lancet 1984; i: 665-668.
-
(1984)
Lancet
, vol.1
, pp. 665-668
-
-
Speck, B.1
Bortin, M.M.2
Champlin, R.3
-
11
-
-
0025860239
-
Chronic graft-versus-host disease and other late complications of bone marrow transplantation
-
Sullivan KM, Agura E, Anasetti C et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250-259.
-
(1991)
Semin. Hematol.
, vol.28
, pp. 250-259
-
-
Sullivan, K.M.1
Agura, E.2
Anasetti, C.3
-
12
-
-
0032480589
-
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
-
1352
-
Gratwohl A, Hermans J, Goldman JM et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Lancet 1998; 1352: 1087-1092.
-
(1998)
Lancet
, pp. 1087-1092
-
-
Gratwohl, A.1
Hermans, J.2
Goldman, J.M.3
-
13
-
-
0034886376
-
Clinicopathologic characteristics of leukemia in Japanese children and young adults
-
Horibe K, Tsukimoto I, Ohno R. Clinicopathologic characteristics of leukemia in Japanese children and young adults. Leukemia 2001; 15: 1256-1261.
-
(2001)
Leukemia
, vol.15
, pp. 1256-1261
-
-
Horibe, K.1
Tsukimoto, I.2
Ohno, R.3
-
14
-
-
0027980844
-
Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
-
Clift RA, Bukner CD, Thomas ED et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 184: 2036-2043.
-
(1994)
Blood
, vol.184
, pp. 2036-2043
-
-
Clift, R.A.1
Bukner, C.D.2
Thomas, E.D.3
-
15
-
-
0034668122
-
Therapeutic choices in younger patients with chronic myelogenous leukemia
-
Kantarjian HM, Giles FJ, O'Brien S et al. Therapeutic choices in younger patients with chronic myelogenous leukemia. Cancer 2000; 89: 1647-1658.
-
(2000)
Cancer
, vol.89
, pp. 1647-1658
-
-
Kantarjian, H.M.1
Giles, F.J.2
O'Brien, S.3
-
16
-
-
0033485291
-
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure
-
Hehlmann R, Hochhaus A, Kolb HJ et al. Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure. Blood 1999; 94: 3668-3677.
-
(1999)
Blood
, vol.94
, pp. 3668-3677
-
-
Hehlmann, R.1
Hochhaus, A.2
Kolb, H.J.3
-
17
-
-
6844259874
-
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myeloid leukemia
-
Gale RP, Hehlmann R, Zhang MJ et al. Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myeloid leukemia. Blood 1998; 91: 1810-1819.
-
(1998)
Blood
, vol.91
, pp. 1810-1819
-
-
Gale, R.P.1
Hehlmann, R.2
Zhang, M.J.3
-
18
-
-
0022643765
-
Bone marrow transplantation for patients with chronic myeloid leukemia
-
Goldman J, Apperley JF, Jones L et al. Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 1986; 314: 202-209.
-
(1986)
N. Engl. J. Med.
, vol.314
, pp. 202-209
-
-
Goldman, J.1
Apperley, J.F.2
Jones, L.3
-
19
-
-
0030707663
-
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: A report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
-
Van Rhee F, Szydlo RM, Hermans J et al. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1997; 20: 553-560.
-
(1997)
Bone Marrow Transplant.
, vol.20
, pp. 553-560
-
-
Van Rhee, F.1
Szydlo, R.M.2
Hermans, J.3
-
20
-
-
8944221180
-
Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Early transplantation, use of an unrelated donor and chronic graft-versus-host disease are protective
-
Enright H, Davis SM, Defor T et al. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor and chronic graft-versus-host disease are protective. Blood 1996; 88: 714-720.
-
(1996)
Blood
, vol.88
, pp. 714-720
-
-
Enright, H.1
Davis, S.M.2
Defor, T.3
-
21
-
-
0345188619
-
Monitoring treatment and survival in chronic myeloid leukemia
-
The Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation
-
The Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation. Monitoring treatment and survival in chronic myeloid leukemia. J Clin Oncol 1999; 17: 1858-1868.
-
(1999)
J. Clin. Oncol.
, vol.17
, pp. 1858-1868
-
-
-
22
-
-
0027376925
-
Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and Volunteer unrelated donors
-
Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and Volunteer unrelated donors. Ann Intern Med 1993; 119: 207-212.
-
(1993)
Ann. Intern. Med.
, vol.119
, pp. 207-212
-
-
Marks, D.I.1
Cullis, J.O.2
Ward, K.N.3
-
23
-
-
7344266888
-
Unrelated donor marrow transplantation for chronic myelogenous leukemia
-
Dini G, Lamparelli T, Rondelli et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia. Br J Haematol 1998; 102: 544-552.
-
(1998)
Br. J. Haematol.
, vol.102
, pp. 544-552
-
-
Dini, G.1
Lamparelli, T.2
Rondelli, A.3
-
24
-
-
0029164624
-
The significance of HLA6DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation
-
Pertersdorf EW, Longton, GM, Anasetti C et al. The significance of HLA6DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995; 86: 1606-1613.
-
(1995)
Blood
, vol.86
, pp. 1606-1613
-
-
Pertersdorf, E.W.1
Longton, G.M.2
Anasetti, C.3
-
25
-
-
0034772639
-
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukemia: A retrospective analysis
-
Bornhausen M, Kiehl M, Siegert W et al. Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukemia: a retrospective analysis. Br J Haematol 2001; 115: 119-124.
-
(2001)
Br. J. Haematol.
, vol.115
, pp. 119-124
-
-
Bornhausen, M.1
Kiehl, M.2
Siegert, W.3
-
26
-
-
0037085807
-
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: Comparative analysis of unrelated versus matched sibling donor transplantation
-
Weisdorf DJ, Anasetti C, Antin JH et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood 2002; 99: 1971-1977.
-
(2002)
Blood
, vol.99
, pp. 1971-1977
-
-
Weisdorf, D.J.1
Anasetti, C.2
Antin, J.H.3
-
27
-
-
0008947293
-
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
-
Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998; 338: 962-968.
-
(1998)
N. Engl. J. Med.
, vol.338
, pp. 962-968
-
-
Hansen, J.A.1
Gooley, T.A.2
Martin, P.J.3
-
28
-
-
12944309759
-
Unrelated donor marrow transplantation for chronic myelogenous leukemia: The 9 year's experience of the National Donor Program
-
McGlave PB, Shu XO, Wen W et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: the 9 year's experience of the National Donor Program. Blood 2000; 95: 2219-2225.
-
(2000)
Blood
, vol.95
, pp. 2219-2225
-
-
McGlave, P.B.1
Shu, X.O.2
Wen, W.3
-
29
-
-
0036157969
-
Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia
-
Millot F, Brice P, Philippe N et al. Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia. J Pediatr Hematol Oncol 2002; 24: 18-21.
-
(2002)
J. Pediatr. Hematol. Oncol.
, vol.24
, pp. 18-21
-
-
Millot, F.1
Brice, P.2
Philippe, N.3
|